Test Price
2,800 AED✅ Home Collection Available
ETFA Gene (Multiple Acyl‑CoA Dehydrogenase Deficiency) Genetic Test in UAE | 2800 AED | DNA Labs Dubai
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 certified NGS processing with full exon coverage and CNV analysis.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation, connecting you with metabolic specialists.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
This next-generation sequencing test comprehensively analyzes the ETFA gene to diagnose multiple acyl-CoA dehydrogenase deficiency (MADD/glutaric acidemia type II), a rare inherited metabolic disorder affecting fatty acid and amino acid metabolism. Delivered by our ISO 9001:2015-certified genomics lab, the test offers 99.9% diagnostic sensitivity for single nucleotide variants, indels, and copy number variations (CNVs). Results are reported within 21–28 days, equipping physicians to implement personalized dietary modifications, riboflavin supplementation, and family cascade screening.
| Feature | Our NGS Test | Traditional Sanger Sequencing |
|---|---|---|
| Precision | 99.9% sensitivity & full exon coverage + CNV | ~95% for point mutations; can miss large deletions |
| Method | NGS (Illumina® platform, bioinformatic variant filtering) | Sanger sequencing of coding regions only |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
Physician Insight & Safety Protocols
"Genetic testing for MADD is a powerful diagnostic tool, but it must be interpreted within the full clinical and biochemical context. A positive result provides a definitive diagnosis and unlocks targeted therapies such as riboflavin and coenzyme Q10, as well as lifesaving dietary adjustments. I always counsel my patients that this test is a starting point for informed family planning and multidisciplinary metabolic care."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
⚠️ Medication Warning
Do not discontinue, adjust, or initiate any prescribed medication—including riboflavin, carnitine, or CoQ10—without direct consultation with your managing metabolic specialist or geneticist.
Exclusion Criteria & Emergency Red Flags
Clinical Exclusion Criteria
- Active Metabolic Crisis: Patients presenting with hypoglycemia, metabolic acidosis, or hyperammonemia require urgent medical stabilization prior to sample collection.
- Severe Coagulopathy: Uncorrected bleeding disorders or haemodynamic instability necessitate medical clearance before venipuncture.
- Emergency Red Flags: Seek immediate emergency care if you experience severe abdominal pain, persistent vomiting, confusion, lethargy, or seizures—these may indicate an acute metabolic decompensation requiring hospital intervention.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of ETFA gene testing?
ETFA gene sequencing identifies disease-causing mutations responsible for multiple acyl-CoA dehydrogenase deficiency (MADD). The result guides precise diagnosis, personalized dietary management (low-fat, high-carbohydrate), riboflavin supplementation, and cascade screening for at-risk family members.
2. How should I prepare for the blood draw, and is fasting required?
No fasting is necessary for this genetic test. You should remain hydrated and provide a detailed clinical history, including any prior metabolic episodes and a three-generation pedigree chart, during the mandatory pre-test genetic counselling session scheduled before collection.
3. Can this test be performed on a child or infant?
Yes, the test is suitable for paediatric patients, including infants. In compliance with Federal Law No. 2 of 2019, a legal guardian must provide written informed consent and undergo pre-test counselling. If venous access is difficult, a buccal swab or dried blood spot (FTA card) can be used as an alternative specimen type.
UAE Regulatory & Data Privacy Adherence
Your Data & Safety Are Protected
DNA Labs UAE strictly adheres to the highest UAE data protection and healthcare regulatory standards:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the secure collection, processing, and storage of your personal genomic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring the confidentiality and cybersecurity of your electronic health records.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – safeguarding your rights regarding informed consent and clinical safety throughout the diagnostic process.
All genomic data is anonymized for research only upon explicit separate consent. You retain full rights to access, rectify, and request deletion of your data under PDPL.
Clinical & Logistical Metadata
| Test Name | ETFA Gene (Multiple Acyl‑CoA Dehydrogenase Deficiency) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 21–28 Days |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or Saliva (Oragene® DNA Kit) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina® Platform with Full Exon Coverage & CNV Analysis |
| ICD-10-CM Code | E71.320 |
| LOINC Code | 94222-0 |
| DHA Facility License & Laboratory | DHA License 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians